This robust protective effect of Nox2 deficiency on cognition parallels other evidence that has shown that blockade of Nox2 via pharmacological18,19 or genetic deletion19 is protective against cognitive impairments in inflammatory disease models. This evidence concerns the gene CYBB and Cognitive impairment.